company background image
BIOX

Bioceres Crop Solutions NasdaqGS:BIOX Stock Report

Last Price

US$12.19

Market Cap

US$765.9m

7D

-9.1%

1Y

-12.9%

Updated

08 Dec, 2022

Data

Company Financials +
BIOX fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance0/6
Financial Health4/6
Dividends0/6

BIOX Stock Overview

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions.

Bioceres Crop Solutions Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bioceres Crop Solutions
Historical stock prices
Current Share PriceUS$12.19
52 Week HighUS$16.00
52 Week LowUS$9.27
Beta0.42
1 Month Change-11.28%
3 Month Change-14.09%
1 Year Change-12.87%
3 Year Change129.14%
5 Year Changen/a
Change since IPO148.78%

Recent News & Updates

Recent updates

We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Apr 10
We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Mar 17
Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Nov 13
Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Jul 08
Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Jun 16
Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

May 26
What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

May 05
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Apr 05
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Mar 10
Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Feb 12
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Shareholder Returns

BIOXUS ChemicalsUS Market
7D-9.1%-1.7%-2.8%
1Y-12.9%-8.3%-19.6%

Return vs Industry: BIOX underperformed the US Chemicals industry which returned -9.2% over the past year.

Return vs Market: BIOX exceeded the US Market which returned -21.2% over the past year.

Price Volatility

Is BIOX's price volatile compared to industry and market?
BIOX volatility
BIOX Average Weekly Movement7.2%
Chemicals Industry Average Movement6.8%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: BIOX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: BIOX's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001n/aFederico Truccohttps://biocerescrops.com

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates in three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops.

Bioceres Crop Solutions Corp. Fundamentals Summary

How do Bioceres Crop Solutions's earnings and revenue compare to its market cap?
BIOX fundamental statistics
Market CapUS$765.95m
Earnings (TTM)-US$7.58m
Revenue (TTM)US$388.94m

2.0x

P/S Ratio

-101.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BIOX income statement (TTM)
RevenueUS$388.94m
Cost of RevenueUS$242.59m
Gross ProfitUS$146.35m
Other ExpensesUS$153.93m
Earnings-US$7.58m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.12
Gross Margin37.63%
Net Profit Margin-1.95%
Debt/Equity Ratio72.4%

How did BIOX perform over the long term?

See historical performance and comparison